30

MedicalSystem Biotechnology Co LtdSHE 300439 Stock Report

Last reporting period 30 Sep, 2023

Updated 06 Nov, 2024

Last price

Market cap $B

0.513

Micro

Exchange

XSHE - Shenzhen Stock Exchange

300439.SZ Stock Analysis

30

Neutral

Based on Eyestock quantitative analysis, 300439.SZ`s fundamental data and valuation indicate an investment grade of Neutral at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

78/100

Moderate score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

20.3 %

Greatly undervalued

Market cap $B

0.513

Dividend yield

2.66 %

Shares outstanding

383 B

MedicalSystem Biotechnology Co., Ltd. engages in the research, development and manufacturing of bio-tech pharmaceutical products. The company is headquartered in Ningbo, Zhejiang and currently employs 2,406 full-time employees. The company went IPO on 2015-04-22. The Company’s in-vitro diagnostic products include in-vitro diagnostic reagent and in-vitro diagnostic instrument. In addition, the Company is also involved in the provision of third-party medical diagnosis services, as well as the production and distribution of reagent raw materials. The firm mainly operates businesses in domestic market.

View Section: Eyestock Rating